Talk:Tapinarof

This is the talk page for discussing improvements to the Tapinarof article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tapinarof.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Tapinarof/benvitimod

Anypodetos there are claims that tapinarof and benvitimod differ.^[1]^[2] -- Whywhenwhohow (talk) 05:27, 26 May 2022 (UTC)[reply]

Thanks for the links! According to Stein Gold, the two creams are "distinct topical medications that contain the same active component (3,5-dihydroxy-4-isopropyl-trans-stilbene)". Wikipedia usually has articles about active ingredients and discusses different formulations of the same substance, if notable, in the same article. See e.g. Ciclosporin, which is about the oral formulation as well as the eye drops. So I think we should have one article under the INN per Wiki guidelines (which is tapinarof per ChemSpider) and ideally describe the differences between the two formulations here. (Also, describing two different formulations under different names of the same active ingredient is really confusing; at least it was to me.) --ἀνυπόδητος (talk) 07:00, 26 May 2022 (UTC)[reply]

References

^ Stein Gold L, Rubenstein DS, Peist K, Jain P, Tallman AM (September 2021). "Tapinarof cream 1% once daily and benvitimod 1% twice daily are 2 distinct topical medications". J Am Acad Dermatol. 85 (3): e201–e202. doi:10.1016/j.jaad.2021.04.103. PMID 34111499.
^ Assaf J, Sarkis J, Tomb R (September 2021). "Reply to: Tapinarof cream 1% once daily and benvitimod 1% twice daily are two distinct topical medications". J Am Acad Dermatol. 85 (3): e203. doi:10.1016/j.jaad.2021.05.027. PMID 34048851.

Merge

Support merge with Benvitimod as it is the identical substance. Graeme Bartlett (talk) 00:36, 27 May 2022 (UTC)[reply]

[1] Stein Gold L, Rubenstein DS, Peist K, Jain P, Tallman AM (September 2021). "Tapinarof cream 1% once daily and benvitimod 1% twice daily are 2 distinct topical medications". J Am Acad Dermatol. 85 (3): e201–e202. doi:10.1016/j.jaad.2021.04.103. PMID 34111499.

[2] Assaf J, Sarkis J, Tomb R (September 2021). "Reply to: Tapinarof cream 1% once daily and benvitimod 1% twice daily are two distinct topical medications". J Am Acad Dermatol. 85 (3): e203. doi:10.1016/j.jaad.2021.05.027. PMID 34048851.

[1]

[2]